Share page on Facebook Share page on Twitter Share page on LinkedIn

Services

Services

Our services span the entire lifecycle of product development and commercialisation, and can be adapted to suit small local trials or large global programs.
Read more
Services
Clinical Research Services Commercial Positioning Consulting Early Clinical Strategic Solutions Laboratories Language Services Medical Imaging Real World Intelligence Site & Patient Solutions
COVID-19 clinical operations
Clinical trials during COVID-19.

Decentralised & hybrid clinical solutions
Bringing the clinical trial to the patient with innovation and in-home solutions.
Sectors

Sectors

ICON provides its full range of clinical, consulting and commercial services across several industry sectors.
Read more
Sectors
Biosimilars Biotech Government & Public Health Solutions Medical Device Pharmaceuticals
The IVDR journey
A roadmap to meet 2022 deadlines, while navigating pandemic disruptions.

Biotech
Developing transformative therapies requires a flexible approach.
Therapeutics

Therapeutics

We have extensive experience in a broad range of therapeutic areas. Managing studies in all major geographies, we have established solid working relationships with the world’s leading investigators.
Read more
Therapeutics
Cardiovascular Cell and Gene Therapies Central Nervous System Endocrine & Metabolic Disorders Infectious Diseases Internal Medicine & Immunology Medical Device Oncology Paediatrics Rare & Orphan Diseases Transplant Immunology Women's Health
Vaccines
ICON has lead the development of 18 vaccines resulting in FDA/EMA approvals, including the world’s first approved vaccine for COVID-19.

Therapeutics insights
ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.
Innovation

Innovation

We develop integrated technologies to significantly enhance the efficiency and productivity of clients’ drug and device development programs.
Read more
Innovation
FIRECREST ICON Digital Platform Safety Reporting Solution One Search Evidence Platform FLEX ADVANTAGE Medical Imaging Technology NONMEM ICONIK PDx-POP PubsHub SIMS ICOMaster for eTMF Control Tower Prism eClinical Solution
FIRECREST
With travel restrictions due to COVID-19, FIRECREST helps deliver and manage remote training for investigators.

ICON Digital Platform
Harmonising data and services for more integrated decentralised clinical trials.
Insights

Insights

BioPharma companies and Medical Devices manufacturers face growing operational, regulatory and economic challenges. ICON provides analysis and key insights on these challenges, with practical advice and recommendations.
Read more
Insights
Digital Disruption Patient Centricity Regulatory Intelligence Therapeutics insights Transforming Trials Value Based Healthcare Blog Videos Webinar Channel
Diversity and inclusion in clinical trials
Establishing a platform for improvement

Decentralised & hybrid clinical trials
Patient focused research for better outcomes.
News & Events

News & Events

ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.
Read more
News & Events
Press releases In the News Mediakit Awards Events Webinars Social media
Webinar: Medicare Part D - Price negotiation panel discussion
Register today

Webinar: Rare disease week 2023 - Exploring accessibility in rare disease clinical research
Register today
About ICON

About ICON

Our mission is to help clients accelerate the development of drugs and devices that save lives and improve quality of life.
Read more
About ICON
Company history ICON in Asia Pacific ICON in Latin America Leadership Quality
Environmental, Social and Governance
ICON CARES is our commitment to making a positive impact on our people, environment and our community.

ICON and You
Partners making a difference.

Careers
Investors
Investigators
Patients
Contact
日本語
简体中文

Home
News & Events
In the News
LEO Pharma enters clinical trial partnership with ICON

LEO Pharma enters clinical trial partnership with ICON

This news article, published on PM Live, highlights how the partnership will advance trial execution within medical dermatology.

Related information

LEO Pharma and ICON enter a strategic partnership to propel clinical trial execution within medical dermatology

Dermatology

LEO Pharma and ICON plc collaborate to improve outcomes for dermatology patients

In this section

In this section

Press releases
In the News
Mediakit
- Facts and figures
- ICON Spokespeople
Awards
Events
Webinars
Social media

Connect with us

Contact us
Submit proposal request
Update Email Preferences
Global office locator
ICON on social media

Contact
About ICON
Results & Reports

For Clients

Therapeutics
Services
Insights
Innovation
Content preferences
Office locations

ICON for

Patients
Volunteers
Investigators
Jobs & Careers
Investors
Suppliers

News & Events

Press releases
Mediakit
Events
Social media dashboard

LinkedIn
Twitter
Facebook
Youtube

© 2023 ICON plc
Disclaimer
Privacy
Site Cookies
International Transfers

Connect with us

Contact us Submit proposal request Update Email Preferences Global office locator ICON on social media